SCHEMBL4678950

SCHEMBL4678950

CCN(CC1CCN(C(=O)N(C)C)CC1)C(C)Cc1cccc(C(F)(F)F)c1.O=C(O)C(O)(C(=O)c1ccccc1)C(O)(C(=O)O)C(=O)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMYD3 Q9H7B4 1/20 0.40
USP2 O75604 2/20 0.39
CYP3A4 P08684 2/20 0.39
NR1I2 O75469 1/20 0.39
ADRB1 P08588 1/20 0.39
HTR1A P08908 1/20 0.39
ADRA2A P08913 1/20 0.39
ADORA3 P0DMS8 1/20 0.39
ADRA2B P18089 1/20 0.39
ADRA2C P18825 1/20 0.39
CHRM3 P20309 1/20 0.39
SLC6A2 P23975 1/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
SLC6A4 P31645 1/20 0.39
ADRA1A P35348 1/20 0.39
HRH1 P35367 1/20 0.39
OPRM1 P35372 1/20 0.39
DRD3 P35462 1/20 0.39
HTR2B P41595 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4682945 0.92 SMYD3 (0.45) SMYD3ADRA2CHTR2AHTR2CSLC6A4
SCHEMBL4682885 0.91 RORC (0.40) CHRM3KCNH2CYP2D6CHRM4SIGMAR1
SCHEMBL4682814 0.91 KMT2A (0.40) SMYD3USP2CYP3A4NR1I2ADRB1
SCHEMBL4683626 0.89 NPSR1 (0.38) DRD3CYP2D6NPSR1
Water SCHEMBL4680290 0.88 CNR1 (0.42) SMYD3USP2CYP3A4NR1I2ADRB1
SCHEMBL4679943 0.88 CYP2D6 (0.44) USP2CYP3A4NR1I2ADRB1HTR1A
SCHEMBL4678953 0.88 USP2 (0.42) SMYD3USP2CYP3A4NR1I2ADRB1
SCHEMBL4682466 0.87 KMT2A (0.43) USP2CYP3A4NR1I2ADRB1HTR1A
SCHEMBL4682648 0.84 YAP1 (0.36) CYP2D6NPSR1
Water SCHEMBL4677926 0.82 CHRM3 (0.40) CYP3A4HTR1AADRA2AADRA2BADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1058680-B1 2-ARYLETHYL-(PIPERIDIN-4-YLMETHYL)AMINE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2008-07-09 EP disclosed
US-6319920-B1 MUSCARINIC RECEPTOR ANTAGONIST USED IN GASTROINTESTINAL, GENITOURINARY TRACT, RESPIRATORY TRACT, CARDIOVASCULAR SYSTEM, CENTRAL NERVOUS SYSTEM DISORDERS AND IN ANESTHESIOLOGY AND OPHTHALMOLOGY SYNTEX (U.S.A.) LLC 2001-11-20 US disclosed
EP-1058680-A1 2-ARYLETHYL-(PIPERIDIN-4-YLMETHYL)AMINE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2000-12-13 EP disclosed
WO-1999043657-A1 2-ARYLETHYL-(PIPERIDIN-4-YLMETHYL)AMINE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 1999-09-02 WO disclosed